Zentalis Pharmaceuticals Statistics
NASDAQ: ZNTLHealthcareBiotechnologyUSD
2.51-0.04 (-1.57%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Zentalis Pharmaceuticals by the numbers
Zentalis Pharmaceuticals has a market capitalization of $246.3 million based on 98.12M shares outstanding. With trailing EPS of $-1.93, Zentalis Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.3% below its 50-day average and 27.1% below its 200-day average.
Average daily trading volume is 1.21M shares, or about $3.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ZNTL valuation vs. peer median
| Metric | ZNTL | Peer median | Difference |
|---|---|---|---|
| Market cap | $246.29M | $243.46M | +1% |
| Avg. volume | 1.21M | 886.42K | +36% |
Peer median across 8 companies: UPB, PYXS, BCYC, ALEC, IFRX, GLSI, VNDA, LRMR.
Valuation
- Market cap
- $246.29M
- EPS (TTM)
- $-1.93
- Shares outstanding
- 98.12M
Price and trading
- Previous close
- 2.55
- Open
- 2.50
- Day range
- 2.39 – 2.54
- 52-week range
- 1.21 – 6.95
- 52-week change
- +64.52%
- Beta
- —
- Volume
- 1.27M
- Average volume
- 1.21M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 246.29M
- Forward Pe
- -1.38
- Eps
- -1.93
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.95
- Week52 Low
- 1.21
- Avg Volume
- 1.21M
- Shares Outstanding
- 98.12M
- Ma50
- 3.60
- Ma200
- 3.44
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -63.88%
- Pct From52w Low
- 107.10%